A detailed history of Parallel Advisors, LLC transactions in Surmodics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 212 shares of SRDX stock, worth $7,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
212
Previous 212 -0.0%
Holding current value
$7,216
Previous $8,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$25.39 - $42.1 $5,382 - $8,925
212 New
212 $8,000
Q2 2022

Aug 01, 2022

BUY
$33.25 - $45.11 $7,215 - $9,788
217 New
217 $8,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.